Teva Pharmaceutical Industries Limited (TEVA) Bank of America Global Healthcare Conference (Transcript)Seeking Alpha • 09/19/24
Exclusive: Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources sayReuters • 09/10/24
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of StabilityBenzinga • 09/06/24
Medincell's Partner Teva Provides New Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI)Business Wire • 09/05/24
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/05/24
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewsWire • 08/26/24
Teva Pharmaceutical Industries Limited (TEVA) Q2 2024 Earnings Call TranscriptSeeking Alpha • 07/31/24
Medincell's partner Teva provides update on pivotal clinical Phase 3 of investigational Olanzapine Long-Acting Injectable (LAI) and UZEDY® commercial progressBusiness Wire • 07/31/24
Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 07/31/24
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?Zacks Investment Research • 07/31/24
Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-RaiseInvestors Business Daily • 07/31/24
Teva Pharma lifts annual profit view on strong generic, Huntington's disease drug salesReuters • 07/31/24
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 07/29/24
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel DiseaseBusiness Wire • 07/25/24